Shares of Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) have received a consensus recommendation of “Reduce” from the five analysts that are currently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. The average 12 month target price among analysts that have covered the stock in the last year is $1.75.
A number of brokerages have recently commented on CDLX. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Cardlytics in a report on Monday, December 29th. Wall Street Zen downgraded Cardlytics from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Bank of America reissued an “underperform” rating on shares of Cardlytics in a report on Thursday. Finally, Evercore set a $1.00 price target on Cardlytics in a research report on Friday.
Check Out Our Latest Stock Analysis on Cardlytics
Insiders Place Their Bets
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Personalized Indexing Management LLC purchased a new stake in Cardlytics during the 3rd quarter worth $26,000. Catalyst Funds Management Pty Ltd acquired a new position in Cardlytics in the second quarter worth $32,000. Sand Hill Global Advisors LLC acquired a new stake in shares of Cardlytics during the second quarter worth $35,000. Virtu Financial LLC acquired a new stake in shares of Cardlytics during the fourth quarter worth $39,000. Finally, Y Intercept Hong Kong Ltd bought a new position in shares of Cardlytics in the 2nd quarter worth about $42,000. 68.10% of the stock is owned by institutional investors and hedge funds.
Cardlytics Trading Down 4.4%
Shares of NASDAQ:CDLX opened at $0.78 on Thursday. Cardlytics has a 12-month low of $0.75 and a 12-month high of $3.28. The business has a 50 day moving average of $1.04 and a two-hundred day moving average of $1.36. The company has a market capitalization of $42.94 million, a PE ratio of -0.40, a PEG ratio of 0.12 and a beta of 1.03. The company has a current ratio of 1.75, a quick ratio of 1.14 and a debt-to-equity ratio of 2.87.
Cardlytics (NASDAQ:CDLX – Get Free Report) last announced its quarterly earnings data on Wednesday, March 4th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.08). The company had revenue of $56.10 million during the quarter, compared to analysts’ expectations of $54.46 million. Cardlytics had a negative net margin of 44.36% and a negative return on equity of 370.98%. As a group, analysts forecast that Cardlytics will post -1.52 EPS for the current year.
Cardlytics Company Profile
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
Featured Articles
- Five stocks we like better than Cardlytics
- “I just bought 10,000 shares of a $5 stock…”
- 3 Signs You May Want to Switch Financial Advisors
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- Silver Is the New Oil—And the World’s Running Dry
- Central banks just did something they haven’t done since 1967
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
